Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease

In the central nervous system (CNS), calcium homeostasis is a critical determinant of neuronal survival. Calpain, a calcium-dependent neutral protease, is widely expressed in the brain, including substantia nigra (SN) dopaminergic (DA) neurons. Though calpain is implicated in human Parkinson’s disea...

Full description

Bibliographic Details
Main Authors: Vandana Zaman, Kelsey P. Drasites, Ali Myatich, Ramsha Shams, Donald C. Shields, Denise Matzelle, Azizul Haque, Narendra L. Banik
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/22/13849
_version_ 1797465188122755072
author Vandana Zaman
Kelsey P. Drasites
Ali Myatich
Ramsha Shams
Donald C. Shields
Denise Matzelle
Azizul Haque
Narendra L. Banik
author_facet Vandana Zaman
Kelsey P. Drasites
Ali Myatich
Ramsha Shams
Donald C. Shields
Denise Matzelle
Azizul Haque
Narendra L. Banik
author_sort Vandana Zaman
collection DOAJ
description In the central nervous system (CNS), calcium homeostasis is a critical determinant of neuronal survival. Calpain, a calcium-dependent neutral protease, is widely expressed in the brain, including substantia nigra (SN) dopaminergic (DA) neurons. Though calpain is implicated in human Parkinson’s disease (PD) and corresponding animal models, the roles of specific ubiquitous calpain isoforms in PD, calpain-1 and calpain-2, remain poorly understood. In this study, we found that both isoforms are activated in a nigrostriatal pathway with increased phosphorylated synuclein following the administration of rotenone in Lewis rats, but calpain isoforms played different roles in neuronal survival. Although increased expression of calpain-1 and calpain-2 were detected in the SN of rotenone-administered rats, calpain-1 expression was not altered significantly after treatment with calpain inhibitor (calpeptin); this correlated with neuronal survival. By contrast, increased calpain-2 expression in the SN of rotenone rats correlated with neuronal death, and calpeptin treatment significantly attenuated calpain-2 and neuronal death. Calpain inhibition by calpeptin prevented glial (astroglia/microglia) activation in rotenone-treated rats in vivo, promoted M2-type microglia, and protected neurons. These data suggest that enhanced expression of calpain-1 and calpain-2 in PD models differentially affects glial activation and neuronal survival; thus, the attenuation of calpain-2 may be important in reducing SN neuronal loss in PD.
first_indexed 2024-03-09T18:17:57Z
format Article
id doaj.art-b3698c9774c549a2a0591e18c0e4639e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T18:17:57Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-b3698c9774c549a2a0591e18c0e4639e2023-11-24T08:34:27ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-11-0123221384910.3390/ijms232213849Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s DiseaseVandana Zaman0Kelsey P. Drasites1Ali Myatich2Ramsha Shams3Donald C. Shields4Denise Matzelle5Azizul Haque6Narendra L. Banik7Ralph H. Johnson Veterans Administration Medical Center, 109 Bee St., Charleston, SC 29401, USAThe Citadel, 171 Moultrie St., Charleston, SC 29409, USAThe Citadel, 171 Moultrie St., Charleston, SC 29409, USAThe Citadel, 171 Moultrie St., Charleston, SC 29409, USADepartment of Neurosurgery, Medical University of South Carolina, 96 Jonathan Lucas St., Charleston, SC 29425, USARalph H. Johnson Veterans Administration Medical Center, 109 Bee St., Charleston, SC 29401, USARalph H. Johnson Veterans Administration Medical Center, 109 Bee St., Charleston, SC 29401, USARalph H. Johnson Veterans Administration Medical Center, 109 Bee St., Charleston, SC 29401, USAIn the central nervous system (CNS), calcium homeostasis is a critical determinant of neuronal survival. Calpain, a calcium-dependent neutral protease, is widely expressed in the brain, including substantia nigra (SN) dopaminergic (DA) neurons. Though calpain is implicated in human Parkinson’s disease (PD) and corresponding animal models, the roles of specific ubiquitous calpain isoforms in PD, calpain-1 and calpain-2, remain poorly understood. In this study, we found that both isoforms are activated in a nigrostriatal pathway with increased phosphorylated synuclein following the administration of rotenone in Lewis rats, but calpain isoforms played different roles in neuronal survival. Although increased expression of calpain-1 and calpain-2 were detected in the SN of rotenone-administered rats, calpain-1 expression was not altered significantly after treatment with calpain inhibitor (calpeptin); this correlated with neuronal survival. By contrast, increased calpain-2 expression in the SN of rotenone rats correlated with neuronal death, and calpeptin treatment significantly attenuated calpain-2 and neuronal death. Calpain inhibition by calpeptin prevented glial (astroglia/microglia) activation in rotenone-treated rats in vivo, promoted M2-type microglia, and protected neurons. These data suggest that enhanced expression of calpain-1 and calpain-2 in PD models differentially affects glial activation and neuronal survival; thus, the attenuation of calpain-2 may be important in reducing SN neuronal loss in PD.https://www.mdpi.com/1422-0067/23/22/13849calpaindopaminergic neuronalpha-synucleinmicrogliaParkinson’s diseaserotenone
spellingShingle Vandana Zaman
Kelsey P. Drasites
Ali Myatich
Ramsha Shams
Donald C. Shields
Denise Matzelle
Azizul Haque
Narendra L. Banik
Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
International Journal of Molecular Sciences
calpain
dopaminergic neuron
alpha-synuclein
microglia
Parkinson’s disease
rotenone
title Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
title_full Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
title_fullStr Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
title_full_unstemmed Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
title_short Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
title_sort inhibition of calpain attenuates degeneration of substantia nigra neurons in the rotenone rat model of parkinson s disease
topic calpain
dopaminergic neuron
alpha-synuclein
microglia
Parkinson’s disease
rotenone
url https://www.mdpi.com/1422-0067/23/22/13849
work_keys_str_mv AT vandanazaman inhibitionofcalpainattenuatesdegenerationofsubstantianigraneuronsintherotenoneratmodelofparkinsonsdisease
AT kelseypdrasites inhibitionofcalpainattenuatesdegenerationofsubstantianigraneuronsintherotenoneratmodelofparkinsonsdisease
AT alimyatich inhibitionofcalpainattenuatesdegenerationofsubstantianigraneuronsintherotenoneratmodelofparkinsonsdisease
AT ramshashams inhibitionofcalpainattenuatesdegenerationofsubstantianigraneuronsintherotenoneratmodelofparkinsonsdisease
AT donaldcshields inhibitionofcalpainattenuatesdegenerationofsubstantianigraneuronsintherotenoneratmodelofparkinsonsdisease
AT denisematzelle inhibitionofcalpainattenuatesdegenerationofsubstantianigraneuronsintherotenoneratmodelofparkinsonsdisease
AT azizulhaque inhibitionofcalpainattenuatesdegenerationofsubstantianigraneuronsintherotenoneratmodelofparkinsonsdisease
AT narendralbanik inhibitionofcalpainattenuatesdegenerationofsubstantianigraneuronsintherotenoneratmodelofparkinsonsdisease